Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

OS Therapies Inc

CIK 1795091 OSTX·Pharmaceutical Preparations · All EDGAR filings ↗

Late filing Filing comparison

OS Therapies Inc told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. Filed on the statutory due date.

OS Therapies Incorporated (the “Company”) has determined that it will not be able to file its Quarterly Report on Form 10-Q for its quarter ended March 31, 2026 (the “Form 10-Q”) by May 15, 2026, the original due date for such filing, without unreasonable effort or expense, due to delays in compiling and reviewing certain information included in the Form 10-Q resulting primarily from additional time required for the Company to complete the financial statement close process.
Evidence
Anticipates significant change
No
Days past due date
0
Other periodic reports filed
Yes
Routine
Yes
Severity
normal
Source
Form 12b-25 (notification of late filing)
Stated reason
OS Therapies Incorporated (the “Company”) has determined that it will not be able to file its Quarterly Report on Form 10-Q for its quarter ended March 31, 2026 (the “Form 10-Q”) by May 15, 2026, the original due date for such filing, without unreasonable effort or expense, due to delays in compiling and reviewing certain information included in the Form 10-Q resulting primarily from additional time required for the Company to complete the financial statement close process.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.